Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2005
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511710A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer s disease, type 2 diabetes, and parkinson s disease
03/09/2005EP1511706A1 Preparations containing conjugated linoleic alcohol
03/09/2005EP1511509A1 Compositions and methods for treating diabetes
03/09/2005EP1511502A2 Probiotic therapies using lactobacillus reuteri
03/09/2005EP1511499A2 Immunomodulatory compounds and methods of use thereof
03/09/2005EP1511488A2 Human adam-10 inhibitors
03/09/2005EP1511484A1 Combination of a dpp iv inhibitor and a cardiovascular compound
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1511468A1 Nanoparticulate sterol formulations and sterol combinations
03/09/2005EP1511467A1 Nanoparticulate polycosanol formulations and novel polycosanol combinations
03/09/2005EP1511397A1 Dietary method for modulatng glucose metabolism and associated conditions and increasing longevity
03/09/2005EP1511379A1 Prevention or treatment of abnormal lipoprotein, cholestasis and atherosclerosis
03/09/2005EP1202969B1 Biphenyl derivatives, production thereof and use as medicines
03/09/2005EP1162959B1 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
03/09/2005EP1126849B1 Heterocyclic potassium channel inhibitors
03/09/2005EP0845943B1 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
03/09/2005EP0817627B1 Protein kinase c inhibitors
03/09/2005EP0779076B1 Peptide, a method of obtaining it and a pharmaceutical compound based on it
03/09/2005EP0756005B1 Gene coding for adseverin
03/09/2005CN1592744A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1592739A Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
03/09/2005CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination
03/09/2005CN1592628A Compositions and methods for treatment of diabetes
03/09/2005CN1592626A Homeostasis-maintaining agents
03/09/2005CN1592620A Treating and preventing method of disease relative to cardiac insulin resistance
03/09/2005CN1592615A Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
03/09/2005CN1592582A Product for fooding paste to body system
03/09/2005CN1590395A New type azesaccharide compound, their synthesis method and use as immune inhibitor and glycocidase inhibitor
03/09/2005CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof
03/09/2005CN1590373A Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
03/09/2005CN1589904A Use of hemopoietic stem cell mobilizer in preparation of medicine for treating diabetes
03/09/2005CN1589893A Medicinal composition for treating and preventing high blood fat disease and its preparation method
03/09/2005CN1589889A Extract of plant dendrobii caulis and preparing process and use thereof
03/09/2005CN1589879A Medicinal composition for treating diabetes chronic complication and preparation method of effective component
03/09/2005CN1589845A Preparation technology of crataegus total phenolic acid portion and application
03/09/2005CN1589835A Mulberry leaf extract and its use
03/09/2005CN1589822A Chinese medicine for treating II type diabetes and its preparation method
03/09/2005CN1589813A Chinese medicine for treating biabetes
03/09/2005CN1589804A Chinese medicine extract for treating fatty liver, obesity and its preparation method
03/09/2005CN1589802A Pollen pini soft capsule and its preparation method
03/09/2005CN1589787A New type tatine kind small molecule chemical drug-2
03/09/2005CN1589784A 5-hydroxymethyl -2-furol and its derivative analogue medical use
03/09/2005CN1589782A Dimethyl biguanidine hydrochloride slow release particle and its preparation method
03/09/2005CN1192020C Antidiabetic agents
03/09/2005CN1192015C Cell adhesion inhibitors
03/09/2005CN1192011C Calcium receptor-active arylalkyl amines
03/09/2005CN1191843C Active full-component wheat spear extract and its microcapsule and preparing process
03/09/2005CN1191833C Remedies for periodontosis
03/09/2005CN1191760C Process for preparing nutritional supplement
03/08/2005US6864383 Ophthalmic compositions for treating ocular hypertension
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864280 Hypotensive agents; cardiovascular disorders
03/08/2005US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer
03/08/2005US6864246 Anticholesterol agents
03/08/2005US6864242 Mixtures of arginine, glutamine, proline and acyclic carboxy amines selected from leucine, isoleucine or valine, used as nutraceuticals for prophylaxis of metabolic disorders
03/08/2005US6864241 Amine salt of lignan compounds
03/08/2005US6864229 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
03/08/2005US6862890 Process for production of nanoparticles and microparticles by spray freezing into liquid
03/08/2005CA2480712A1 Chondrocyte therapeutic delivery system
03/03/2005WO2005019219A1 Pyrrolopyrimidinone derivative
03/03/2005WO2005019218A1 Pyrrolopyrimidinethione derivative
03/03/2005WO2005019180A1 6-(2,2,2-TRIFLUOROETHYLAMINO)-7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINE AS A 5-HT2c RECEPTOR AGONIST
03/03/2005WO2005019172A1 Indol-2-amides as glycogen phosphorylase inhibitors
03/03/2005WO2005019151A1 Ppar modulators
03/03/2005WO2005018672A1 Drug containing chymase inhibitor as the active ingredient
03/03/2005WO2005018664A1 Method and cosmetic product containing beta-endorphin, which are intended to limit fatty tissue growth
03/03/2005WO2005018652A1 Micronutrient supplement
03/03/2005WO2005018649A1 Agent for inhibiting the formation of final saccharification product
03/03/2005WO2005018648A1 (20S)-1α-HYDROXY-2-METHYLENE-19-NOR-VITAMIN D3 AND ITS USES
03/03/2005WO2005018637A1 Heterocyclic amide derivatives which possess glycogen phosphorylase inhibitory activity
03/03/2005WO2005018626A1 Pharmaceutical composition comprising a combination of metformin and a statin
03/03/2005WO2005018625A1 Use of colipase-lipase inhibitors in the preparation of a pharmaceutical composition in order to prevent obesity
03/03/2005WO2005018622A1 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
03/03/2005WO2005000892A3 Glp-1 analog fusion plroteins
03/03/2005WO2005000784A3 5-[phenyl, tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl- cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity
03/03/2005WO2004089416A3 Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent
03/03/2005WO2004063166A8 Heterocyclic ppar modulators
03/03/2005WO2003099315A8 A pharmaceutical composition comprising a retro-iverso isomer peptide
03/03/2005WO2003089418A8 Indane acetic acid derivatives and their use as pharmaceutical agents
03/03/2005WO2003042362A3 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
03/03/2005US20050050589 Soya cell strains with high isoflavone content
03/03/2005US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same
03/03/2005US20050049413 Quinoline derivatives
03/03/2005US20050049303 Adamantane derivatives
03/03/2005US20050049293 Increasing effect of released acetylcholine on hepatic muscarinic receptors
03/03/2005US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
03/03/2005US20050049269 For therapy of metabolic and eating disorders
03/03/2005US20050049261 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives
03/03/2005US20050049259 Viricides; for the prophylaxis and treatment of herpes viral infections
03/03/2005US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease
03/03/2005US20050049251 Inhibitors of p38
03/03/2005US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine
03/03/2005US20050049239 Type 2 glycine transporter inhibitors; muscle spasticity, tinnitus, epilepsy neuropathic pain, obesity
03/03/2005US20050049233 Transdermal administering of testosterone
03/03/2005US20050049212 Eating disorders, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, osteoarthritis, gallstones, cancers of the reproductive organs, and sleep apnea; drug screening; diagnosis and therapy; kits; regulates metabolism of triglycerides
03/03/2005US20050049205 Product from rose hips e.g. 3- beta -D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO); arthritis and osteoarthritis
1 ... 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 ... 1298